Addressing vaccine hesitancy in writing - Volume 27, Issue

Since the infamous article by Wakefield et al. was published in 1998, diseases once nearly eradicated are re-emerging. As a result, research has focused on communication strategies that can successfully combat vaccine hesitancy. Current research…

HIV vaccine clinical trials: An overview - Volume 27, Issue

More than 30 years after the discovery of the human immunodeficiency virus as the agent that causes AIDS, an effective vaccine against this deadly disease has yet to be developed. The pathway to the development of a vaccine has been riddled with…

Vaccines and immunotherapies - Volume 27, Issue

The use of vaccines and immunotherapies in medicine dates back to the end of the 18th century and the work of Edward Jenner, the father of immunology. Jenner, building on the observations of John Fewster in 1768, showed that inoculation with the…

Pharmacovigilance for vaccines and immunotherapies - Volume 27, Issue

Although the content of EU Periodic Benefit- Risk Evaluation Reports (PBRERs) for vaccines is governed by the same regulatory framework as applies to other medicinal products, the complex nature of vaccines presents vaccine-specific challenges that…

An introduction to vaccines and immunotherapies - Volume 27, Issue

Vaccines and immunotherapies are among the largest categories for pharmaceutical products, meaning that many medical writers will work in this field. For people new to this area, we describe the basics of how vaccines and immunotherapies work.

Addressing vaccine hesitancy in writing: How has COVID-19 changed hesitancy communication, and what works? - Volume 30, Issue

To address vaccine hesitancy in writing, it is important to put yourself in your reader’s shoes, demonstrate an understanding of the hesitancy, and form an effective response using evidence-based writing techniques, clear communication, courtesy,…

Vaccines and Immunotherapies - Volume 27, Issue

The Webscout - Volume 27, Issue

The first practice of immunisation in western countries dates back as far as 1796 when Eduard Jenner used cowpox to vaccinate a young boy against smallpox. This was soon followed by the first smallpox vaccine in 1798.

News from the EMA - Volume 32, Issue

Anuradha Alahari (section editor)   EMA recommends revocation of authorisation for sickle cell disease medicine Adakveo OPEN framework extended to a wider range of medicines Global regulators agree on way forward to adapt COVID-19 vaccines to…

The Crofter: Sustainable Communications - Volume 30, Issue

Greetings from the croft! In this special issue on medical journalism, we have two contributions that discuss topics that have enjoyed attention in the press: 1. the emerging environmental problem because of the growing drug market for pets, and 2.…